Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
About Us
MitoXcel™ Technology
Pipeline
Sarcopenia/Sarcopenic Obesity
Aging Research Hub
Investors
Contact Us
search
Body Composition
Healthspan
Lifespan
Mitochondria
Muscle
Obesity/Glucose Metabolic Disorders
Sarcopenia/Frailty
Two‑phase model of ageing in mice for improved identification of age‑related and late life metabolic decline
By
kslawin
October 22, 2025
July 2nd, 2026
No Comments
Previous Post
Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
Next Post
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies
Leave a Reply
Cancel Reply
You must be
logged in
to post a comment.
Close Menu
About Us
MitoXcel™ Technology
Pipeline
Sarcopenia/Sarcopenic Obesity
Aging Research Hub
Investors
Contact Us
